Penka Petrova, Chief Development Officer at Trillium Therapeutics Inc. (TRIL), sold 10,624 shares at $11.09 ($118K) on 2021-04-08, disclosed to the SEC on 2021-04-09.
Open-market sale of $118k TRIL by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.09 | 5,312 | $59K | 50.0% |
| 2 | $11.09 | 5,312 | $59K | 50.0% |
| Total | $11.09 avg | 10,624 | $118K | 100% |
| Filing → |
| TRIL | SELL | 2021-01-13 | $8K | — | Filing → |
| TRIL | SELL | 2021-01-12 | $40K | — | Filing → |
| TRIL | SELL | 2021-01-11 | $40K | — | Filing → |